Correction: Safety and Effects of Lactobacillus paracasei TISTR 2593 Supplementation on Improving Cholesterol Metabolism and Atherosclerosis-Related Parameters in Subjects with Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (Nutrients, (2023), 15, 3, (661), 10.3390/nu15030661)

Abstract

Error in Table In the original publication [1], there was a mistake in Table 2 as published. In the table, we quoted the baseline of blood parameter-ALT of the L. paracasei TISTR 2593 group which was at “25.85 ± 418.66 U/L”. The corrected blood parameter appears below. ALT on the baseline of the L. paracasei TISTR 2593 group was “25.85 ± 18.66 U/L”. Text Correction There was an error in the original publication in Materials and Methods and Discussion [1]. We stated that the dose of “L. paracasei TISTR 2593” was at “1.05 × 1010 CFU/g”. A correction has been made to Materials and Methods, Section 2.2., paragraph 2. The correct dose of L. paracasei TISTR 2593 is “1.05 × 109 CFU/g”. A correction has been made to Discussion, paragraphs 1 and 2. The correct dose of L. paracasei TISTR 2593 is “1.05 × 109 CFU/g”.